Biologic modulation in renal regeneration

Expert Opinion on Biological Therapy

Volumn 16, Issue 11, 2016, Pages 1403-1415

  Mazzinghi, Benedetta ^a   Romagnani, Paola ^a,b,c   Lazzeri, Elena ^c  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

AKI; Chronic renal failure; CKD; glomerulus; progression; tubule

Indexed keywords

BETA CATENIN; BIOLOGICAL FACTOR; BIOLOGICAL PRODUCT; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; MICRORNA; NOTCH RECEPTOR; STROMAL CELL DERIVED FACTOR 1; WNT PROTEIN;

CELL CYCLE REGULATION; CELL HYPOXIA; CHRONIC KIDNEY DISEASE; EPIGENETICS; GLOMERULUS; HUMAN; INFLAMMATION; KIDNEY FIBROSIS; KIDNEY TUBULE; NONHUMAN; OXIDATIVE STRESS; PODOCYTE; REGENERATION; RENAL PROGENITOR; RENAL REGENERATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION; STEM CELL;

EID: 84989327932     PISSN: 14712598     EISSN: 17447682     Source Type: Journal    
DOI: 10.1080/14712598.2016.1219336     Document Type: Review

References (100)

1. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease:evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1–S266.
2. A.S.Levey, J.Coresh Chronic kidney disease. Lancet. 2012;379:165–180. doi:10.1016/S0140-6736(11)60178-5.
3. M.T.James, B.R.Hemmelgarn, M.Tonelli. Early recognition and prevention of chronic kidney disease. Lancet. 2010;375:1296–1309. doi:10.1016/S0140-6736(09)62004-3.
4. R.L.Mehta, J.Cerda, E.A.Burdmann, et al. International Society of Nephrology’s 0by25 initiative for acute kidney injury (zero preventable deaths by 2025):a human rights case for nephrology. Lancet. 2015;385:2616–2643. doi:10.1016/S0140-6736(15)60126-X.
5. L.S.Chawla, P.W.Eggers, R.A.Star, et al. Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med. 2014;371:58–66. doi:10.1056/NEJMra1214243.
6. A.Ishani, J.L.Xue, J.Himmelfarb, et al. Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol. 2009;20:223–228. doi:10.1681/ASN.2007080837.
7. M.H.Little. Regrow or repair:potentialregenerative therapies for the kidney. J Am Soc Nephrol. 2006;17:2390–2401. doi:10.1681/ASN.2006030218.
8. C.Sagrinati, E.Ronconi, E.Lazzeri, et al. Stem-cell approaches for kidney repair:choosing the right cells. Trends Mol Med. 2008;14:277–285. doi:10.1016/j.molmed.2008.05.005.
9. A.Benigni, M.Morigi, G.Remuzzi. Kidney regeneration. Lancet. 2010;375:1310–1317. doi:10.1016/S0140-6736(10)60237-1.• This review summararizes the recent literature on the evidence that the regeneration in the kidney can occur.
10. P.Fioretto, M.W.Steffes, D.E.Sutherland, et al. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med. 1998;339:69–75. doi:10.1056/NEJM199807093390202.• This article shows the first clinical evidence of glomerular regeneration.
11. P.Fioretto, D.E.Sutherland, B.Najafian, et al. Remodeling of renal interstitial and tubular lesions in pancreas transplant recipients. Kidney Int. 2006;69:907–912. doi:10.1038/sj.ki.5000153.
12. P.Ruggenenti, A.Perna, R.Benini, et al. In chronic nephropathies prolonged ACE inhibition can induce remission:dynamics of time-dependent changes in GFR. Investigators of the GISEN Group. Gruppo Italiano Studi Epidemiologici in Nefrologia. J Am Soc Nephrol. 1999;10:997–1006.
13. P.Ruggenenti, E.Perticucci, P.Cravedi, et al. Role of remission clinics in the longitudinal treatment of CKD. J Am Soc Nephrol. 2008;19:1213–1224. doi:10.1681/ASN.2007090970.• The results of a multimodal intervention to target urinary proteins in 56 consecutive patients are reported.
14. P.Ruggenenti, B.M.Brenner, G.Remuzzi. Remission achieved in chronic nephropathy by a multidrug approach targeted at urinary protein excretion. Nephron. 2001;88:254–259.
15. A.Remuzzi, E.Gagliardini, F.Sangalli, et al. ACE inhibition reduces glomerulosclerosis and regenerates glomerular tissue in a model of progressive renal disease. Kidney Int. 2006;69:1124–1130. doi:10.1038/sj.ki.5000060.
16. J.J.Boffa, Y.Lu, S.Placier, et al. Regression of renal vascular and glomerular fibrosis:role of angiotensin II receptor antagonism and matrix metalloproteinases. J Am Soc Nephrol. 2004;14:1132–1144. doi:10.1097/01.ASN.0000060574.38107.3B.
17. W.Pichaiwong, K.L.Hudkins, T.Wietecha, et al. Reversibility of structural and functional damage in a model of advanced diabetic nephropathy. J Am Soc Nephrol. 2013;24:1088–1102. doi:10.1681/ASN.2012050445.
18. L.J.Ma, S.Nakamura, J.C.Aldigier, et al. Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1. J Am Soc Nephrol. 2005;16:966–976. doi:10.1681/ASN.2004060492.
19. R.C.Wiggins. The spectrum of podocytopathies:A unifying view of glomerular diseases. Kidney Int. 2007;71:1205–1214. doi:10.1038/sj.ki.5002222.
20. D.Macconi, F.Sangalli, M.Bonomelli, et al. Podocyte repopulation contributes to regression of glomerular injury induced by ACE inhibition. Am J Pathol. 2009;174:797–807. doi:10.2353/ajpath.2009.080227.
21. P.Romagnani. Toward the identification of a “renopoietic system”? Stem Cells. 2009;27:2247–2253. doi:10.1002/stem.140.
22. P.Romagnani, L.Lasagni, G.Remuzzi. Renal progenitors:an evolutionary conserved strategy for kidney regeneration. Nat Rev Nephrol. 2013;9:137–146. doi:10.1038/nrneph.2012.290.
23. S.J.Shankland, B.Smeets, J.W.Pippin, et al. The emergence of the glomerular parietal epithelial cell. Nat Rev Nephrol. 2014;10:158–173. doi:10.1038/nrneph.2014.1.
24. M.L.Angelotti, E.Ronconi, L.Ballerini, et al. Characterization of renal progenitors committed toward tubular lineage and their regenerative potential in renal tubular injury. Stem Cells. 2012;30:1714–1725. doi:10.1002/stem.1130.
25. C.Sagrinati, G.S.Netti, B.Mazzinghi, et al. Isolation and characterization of multipotent progenitor cells from the Bowman’s capsule of adult human kidneys. J Am Soc Nephrol. 2006;17:2443–2456. doi:10.1681/ASN.2006010089.• The identification and characterization of renal progenitor cells in adult human kidneys. The ability of these cells to repair renal damage suggests their potential in the treatment of renal failure.
26. E.Ronconi, C.Sagrinati, M.L.Angelotti, et al. Regeneration of glomerular podocytes by human renal progenitors. J Am Soc Nephrol. 2009;20:322–332. doi:10.1681/ASN.2008070709.
27. D.Appel, D.B.Kershaw, B.Smeets, et al. Recruitment of podocytes from glomerular parietal epithelial cells. J Am Soc Nephrol. 2009;20:333–343. doi:10.1681/ASN.2008070795.
28. K.Berger, K.Schulte, P.Boor, et al. The regenerative potential of parietal epithelial cells in adult mice. J Am Soc Nephrol. 2014;25:693–705. doi:10.1681/ASN.2013050481.
29. N.Wanner, B.Hartleben, N.Herbach, et al. Unraveling the role of podocyte turnover in glomerular aging and injury. J Am Soc Nephrol. 2014;25:707–716. doi:10.1681/ASN.2013050452.
30. D.G.Eng, M.W.Sunseri, N.V.Kaverina, et al. Glomerular parietal epithelial cells contribute to adult podocyte regeneration in experimental focal segmental glomerulosclerosis. Kidney Int. 2015;88:999–1012. doi:10.1038/ki.2015.152.
31. P.Romagnani, G.Remuzzi. Renal progenitors in non-diabetic and diabetic nephropathies. Trends Endocrinol Metab. 2013;24:13–20. doi:10.1016/j.tem.2012.09.002.
32. L.Lasagni, P.Romagnani. Glomerular epithelial stem cells:the good, the bad, and the ugly. J Am Soc Nephrol. 2010;21:1612–1619. doi:10.1681/ASN.2009121291.
33. B.Smeets, S.Uhlig, A.Fuss, et al. Tracing the origin of glomerular extracapillary lesions from parietal epithelial cells. J Am Soc Nephrol. 2009;20:2604–2615. doi:10.1681/ASN.2008121233.
34. B.Smeets, C.Kuppe, E.M.Sicking, et al. Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis. J Am Soc Nephrol. 2011;22:1262–1274. doi:10.1681/ASN.2010090970.
35. B.Smeets, M.L.Angelotti, P.Rizzo, et al. Renal progenitor cells contribute to hyperplastic glomerular lesions of different types of podocytopathies and in crescentic glomerulonephritis. J Am Soc Nephrol. 2009;20:2593–2603. doi:10.1681/ASN.2008121233.
36. L.Lasagni, M.L.Angelotti, E.Ronconi, et al. Podocyte regeneration driven by renal progenitors determines glomerular disease remission and can be pharmacologically enhanced. Stem Cell Reports. 2015;5:248–263. doi:10.1016/j.stemcr.2015.07.003.•• This study demonstrates that the regenerative response of RPCs to podocyte injury influences the outcome of CKD.
37. J.W.Pippin, M.A.Sparks, S.T.Glenn, et al. Cells of renin lineage are progenitors of podocytes and parietal epithelial cells in experimental glomerular disease. Am J Pathol. 2013;183:542–557. doi:10.1016/j.ajpath.2013.04.024.
38. C.Starke, H.Betz, L.Hickmann, et al. Renin lineage cells repopulate the glomerular mesangium after injury. J Am Soc Nephrol. 2015;26:48–54. doi:10.1681/ASN.2014030265.
39. P.Rizzo, N.Perico, E.Gagliardini, et al. Nature and mediators of parietal epithelial cell activation in glomerulonephritides of human and rat. Am J Pathol. 2013;183:1769–1778. doi:10.1016/j.ajpath.2013.08.008.•• This study demonstrates the role of ACE inhibitors in podocyte repopulation, contributing to regression of glomerular injury through a reduction of RPC proliferation.
40. M.N.Darisipudi, O.P.Kulkarni, S.G.Sayyed, et al. Dual blockade of the homeostatic chemokine CXCL12 and the proinflammatory chemokine CCL2 has additive protective effects on diabetic kidney disease. Am J Pathol. 2011;179:116–124. doi:10.1016/j.ajpath.2011.03.004.
41. L.Lasagni, L.Ballerini, M.L.Angelotti, et al. Notch activation differentially regulates renal progenitors proliferation and differentiation toward the podocyte lineage in glomerular disorders. Stem Cells. 2010;28:1674–1685. doi:10.1002/stem.492.
42. T.Ueno, N.Kobayashi, M.Nakayama, et al. Aberrant Notch1-dependent effects on glomerular parietal epithelial cells promotes collapsing focal segmental glomerulosclerosis with progressive podocyte loss. Kidney Int. 2013;83:1065–1075. doi:10.1038/ki.2013.48.
43. S.Grouls, D.M.Iglesias, N.Wentzensen, et al. Lineage specification of parietal epithelial cells requires β-catenin/Wnt signaling. J Am Soc Nephrol. 2012;23:63–72. doi:10.1681/ASN.2010121257.
44. J.Wu, C.Zheng, Y.Fan, et al. Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids. J Am Soc Nephrol. 2014;25:92–104. doi:10.1681/ASN.2012111101.
45. L.Kietzmann, S.S.Guhr, T.N.Meyer, et al. MicroRNA-193a regulates the transdifferentiation of human parietal epithelial cells toward a podocyte phenotype. J Am Soc Nephrol. 2015;26:1389–1401. doi:10.1681/ASN.2014020190.
46. A.Benigni, M.Morigi, P.Rizzo, et al. Inhibiting angiotensin-converting enzyme promotes renal repair by limiting progenitor cell proliferation and restoring the glomerular architecture. Am J Pathol. 2011;179:628–638. doi:10.1016/j.ajpath.2011.04.003.
47. J.Lichtnekert, N.V.Kaverina, D.G.Eng, et al. Renin-angiotensin-aldosterone system inhibition increases podocyte derivation from cells of renin lineage. J Am Soc Nephrol. 2016 [Epub ahead of print].
48. J.Zhang, J.W.Pippin, R.D.Krofft, et al. Podocyte repopulation by renal progenitor cells following glucocorticoids treatment in experimental FSGS. Am J Physiol Renal Physiol. 2013;304:F1375–89. doi:10.1152/ajprenal.00020.2013.
49. A.Migliorini, M.L.Angelotti, S.R.Mulay, et al. The antiviral cytokines IFN-α and IFN-β modulate parietal epithelial cells and promote podocyte loss:implications for IFN toxicity, viral glomerulonephritis, and glomerular regeneration. Am J Pathol. 2013;183:431–440. doi:10.1016/j.ajpath.2013.04.017.
50. A.Peired, M.L.Angelotti, E.Ronconi, et al. Proteinuria impairs podocyte regeneration by sequestering retinoic acid. J Am Soc Nephrol. 2013;24:1756–1768. doi:10.1681/ASN.2012090950.
51. H.J.Anders, P.Romagnani, A.Mantovani. Pathomechanisms:homeostatic chemokines in health, tissue regeneration, and progressive diseases. Trends Mol Med. 2014;20:154–165. doi:10.1016/j.molmed.2013.12.002.
52. L.Lasagni, E.Lazzeri, S.J.Shankland, et al. Podocyte mitosis - a catastrophe. Curr Mol Med. 2013;13:13–23.
53. F.Sallustio, G.Serino, V.Costantino, et al. miR-1915 and miR-1225-5p regulate the expression of CD133, PAX2 and TLR2 in adult renal progenitor cells. PLoS One. 2013;8:e68296. doi:10.1371/journal.pone.0068296.
54. B.Bussolati, A.Moggio, F.Collino, et al. Hypoxia modulates the undifferentiated phenotype of human renal inner medullary CD133+ progenitors through Oct4/miR-145 balance. Am J Physiol Renal Physiol. 2012;302:F116–F128. doi:10.1152/ajprenal.00184.2011.
55. C.A.Gebeshuber, C.Kornauth, L.Dong, et al. Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1. Nat Med. 2013;19:481–487. doi:10.1038/nm.3142.
56. N.Guo, J.Guo, D.Su. MicroRNA-206 and its down-regulation of Wilms’Tumor-1 dictate podocyte health in adriamycin-induced nephropathy. Ren Fail. 2016;38:989–995 [Epub ahead of print]. doi:10.3109/0886022X.2016.1165119.
57. A.Remuzzi, F.Sangalli, D.Macconi, et al. Regression of renal disease by angiotensin II antagonism is caused by regeneration of kidney vasculature. J Am Soc Nephrol. 2016;27:699–705. doi:10.1681/ASN.2014100971.
58. A.A.Sharfuddin, B.A.Molitoris. Pathophysiology of ischemic acute kidney injury. Nat Rev Nephrol. 2011;7:189–200. doi:10.1038/nrneph.2011.16.
59. A.Zuk, J.V.Bonventre. Acute kidney injury. Annu Rev Med. 2016;67:293–307. doi:10.1146/annurev-med-050214-013407.
60. B.D.Humphreys, M.T.Valerius, A.Kobayashi, et al. Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell. 2008;2:284–291. doi:10.1016/j.stem.2008.01.014.
61. R.Bellomo, J.A.Kellum, C.Ronco. Acute kidney injury. Lancet. 2012;380:756–766. doi:10.1016/S0140-6736(11)61454-2.
62. Y.Rinkevich, D.T.Montoro, H.Contreras-Trujillo, et al. In vivo clonal analysisreveals lineage-restricted progenitor characteristics in mammalian kidney development, maintenance, and regeneration. Cell Rep. 2014;7:1270–1283. doi:10.1016/j.celrep.2014.05.022.• This study demonstrates that adult damaged kidneys undergo tubulogenesis through clonal expansion of a small subset of tubular cells, suggesting the existence of tubular-committed progenitors as responsible of the repair.
63. D.Lindgren, A.-K.Boström, K.Nilsson, et al. Isolation and characterization of progenitor-like cells from human renal proximal tubules. Am J Pathol. 2011;178:828–837. doi:10.1016/j.ajpath.2010.10.026.
64. B.Smeets, P.Boor, H.Dijkman, et al. Proximal tubular cells contain a phenotypically distinct, scatteredcell population involved in tubular regeneration. J Pathol. 2013;229:645–659. doi:10.1002/path.4125.
65. J.Hansson, K.Hultenby, C.Cramnert, et al. Evidence for a morphologically distinct and functionally robust cell type in the proximal tubules of human kidney. Hum Pathol. 2014;45:382–393. doi:10.1016/j.humpath.2013.10.003.
66. J.V.Bonventre, L.Yang. Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest. 2011;121:4210–4221. doi:10.1172/JCI57873.
67. D.P.Basile. The endothelial cell in ischemic acute kidney injury:implications for acute and chronic function. Kidney Int. 2007;72:151–156. doi:10.1038/sj.ki.5002580.
68. R.Kramann, M.Tanaka, B.D.Humphreys. Fluorescence microangiography for quantitative assessment of peritubular capillarychanges after AKI in mice. J Am Soc Nephrol. 2014;25:1924–1931. doi:10.1681/ASN.2013101121.
69. L.Yang, T.Y.Besschetnova, C.R.Brooks, et al. Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med. 2010;16:535–543. doi:10.1038/nm1110-1167.•• This study demonstrates the association of G2/M arrest and production of profibrogenic growth factors from the tubular cells provide strong evidence that tubular cells arrested in G2/M have a primary role in determining the fibrotic response.
70. J.Kim, Y.M.Seok, K.-J.Jung, et al. Reactive oxygen species/oxidative stress contributes to progression of kidney fibrosis following transient ischemic injury in mice. Am J Physiol Renal Physiol. 2009;297:F461–F470. doi:10.1152/ajprenal.90735.2008.
71. D.P.Basile, E.C.Leonard, A.G.Beal, et al. Persistent oxidative stress following renal ischemia-reperfusion injury increases ANG II hemodynamic and fibrotic activity. Am J Physiol Renal Physiol. 2012;302:F1494–F1502. doi:10.1152/ajprenal.00691.2011.
72. P.P.Kapitsinou, J.Jaffe, M.Michael, et al. Preischemic targeting of HIF prolyl hydroxylation inhibits fibrosis associated with acute kidney injury. Am J Physiol Renal Physiol. 2012;302:F1172–79. doi:10.1152/ajprenal.00667.2011.
73. E.C.Leonard, J.L.Friedrich, D.P.Basile. VEGF-121 preserves renal microvessel structureand ameliorates secondary renal disease following acute kidney injury. Am J Physiol Renal Physiol. 2008;295:F1648–57. doi:10.1152/ajprenal.00099.2008.
74. M.Liu, N.M.Reddy, E.M.Higbee, et al. The Nrf2 triterpenoid activator, CDDO-imidazolide, protects kidneys from ischemia-reperfusion injury in mice. Kidney Int. 2014;85:134–141. doi:10.1038/ki.2013.357.
75. J.Wu, X.Liu, J.Fan, et al. Bardoxolone methyl (BARD) ameliorates aristolochic acid (AA)-induced acute kidney injury through Nrf2 pathway. Toxicology. 2014;318:22–31. doi:10.1016/j.tox.2014.01.008.
76. S.Lee, S.Huen, H.Nishio, et al. Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol. 2011;22:317–326. doi:10.1681/ASN.2009060615.
77. M.-Z.Zhang, B.Yao, S.Yang, et al. CSF-1 signaling mediates recovery fromacute kidney injury. J Clin Invest. 2012;122:4519–4532. doi:10.1172/JCI57313.
78. H.-J.Anders, L.Schaefer. Beyond tissue injury damage-associated molecular patterns, toll like receptors, and inflammasomes also drive regeneration and fibrosis. J Am Soc Nephrol. 2014;25:1387–1400. doi:10.1681/ASN.2014010117.
79. O.P.Kulkarni, I.Hartter, S.R.Mulay, et al. Toll-like receptor 4-induced IL-22 accelerates kidney regeneration. J AmSoc Nephrol. 2014;25:978–989. doi:10.1681/ASN.2013050528.
80. E.R.Barry, T.Morikawa, B.L.Butler, et al. Restriction of intestinal stem cell expansion and the regenerative response by YAP. Nature. 2013;493:106–110. doi:10.1038/nature11818.
81. J.L.Grijalva, M.Huizenga, K.Mueller, et al. Dynamic alterations in Hippo signaling pathway and YAP activation during liver regeneration. Am J Physiol Gastrointest Liver Physiol. 2014;307:G196–G204. doi:10.1152/ajpgi.00144.2014.
82. J.Xu, P.X.Li, J.Wu, et al. Involvement of the Hippo pathway in regeneration and fibrogenesis after ischaemic acute kidney injury:YAP is the key effector. Clin Sci. 2016;130:349–363. doi:10.1042/CS20150385.
83. S.G.Szeto, M.Narimatsu, M.Lu, et al. YAP/TAZ are mechanoregulators of TGF-β-smad signaling and renal fibrogenesis. J Am Soc Nephrol. 2016 [Epub ahead of print].
84. Y.Sirin, K.Susztak. Notch in the kidney:development and disease. J Pathol. 2012;226:394–403. doi:10.1002/path.2967.
85. B.Bielesz, Y.Sirin, H.Si, et al. Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans.J. Clin Invest. 2010;120:4040–4054.
86. J.Kramer, R.Schwanbeck, H.Pagel, et al. Inhibition of Notch signaling ameliorates acute kidney failure and downregulates platelet-derived growth factor receptor β in the mouse model. Cells Tissues Organs. 2016;201:109–117. doi:10.1159/000442463.
87. P.M.Price, R.L.Safirstein, J.Megyesi. The cell cycle and acute kidney injury. Kidney Int. 2009;76:604–613. doi:10.1038/ki.2009.290.
88. J.Megyesi, R.L.Safirstein, P.M.Price. Inductionof p21WAF1/CIP1/SDI1 in kidney tubule cells affects the course of cisplatin-induced acute renal failure. J Clin Invest. 1998;101:777–782. doi:10.1172/JCI2325.
89. D.P.Di Rocco, J.Bisi, P.Roberts, et al. CDK4/6 inhibition induces epithelial cell cycle arrest and ameliorates acute kidney injury. Am J Physiol Renal Physiol. 2014;306:F379– 88. doi:10.1152/ajprenal.00675.2013.
90. J.A.Kellum, L.S.Chawla. Cell-cycle arrest and acute kidney injury:the light and the dark sides. Nephrol Dial Transplant. 2016 Jan;31(1):16–22. doi:10.1093/ndt/gfv130.
91. L.S.Chawla, P.L.Kimmel. Acute kidney injury and chronic kidney disease:an integrated clinical syndrome. Kidney Int. 2012;82:516–524. doi:10.1038/ki.2012.208.
92. S.Lovisa, V.S.LeBleu, B.Tampe, et al. Epithelial-to-mesenchymal transition induces cell-cycle arrest and parenchymal damage in renal fibrosis. Nat Med. 2015;21:998–1009. doi:10.1038/nm.3902.•• This study provides strong evidence that tubular cells arrested G2/M have a primary role in determining the fibrotic response and that the percentage of cells that underwent G2/M arrest correlate with the development of fibrosis.
93. C.Cianciolo Cosentino, N.I.Skrypnyk, L.L.Brilli, et al. Histone deacetylase inhibitor enhances recovery after AKI. J Am Soc Nephrol. 2013;24:943–953. doi:10.1681/ASN.2012111055.
94. J.Tang, N.Liu, E.Tolbert, et al. Sustained activation of EGFR triggers renal fibrogenesis after acute kidney injury. Am J Pathol. 2013;183:160–172. doi:10.1016/j.ajpath.2013.04.005.
95. F.E.Cuppage, A.Tate. Repair of the nephron following injury with mercuric chloride. Am J Pathol. 1967;51:405–429.
96. E.D.De Groh, L.M.Swanhart, C.C.Cosentino, et al. Inhibition of histone deacetylase expands the renal progenitor cell population. J Am Soc Nephrol. 2010;21:794–802. doi:10.1681/ASN.2009080851.
97. K.Van Beneden, C.Geers, M.Pauwels, et al. Valproic acid attenuates proteinuria and kidney injury. J Am Soc Nephrol. 2011;22:1863–1875. doi:10.1681/ASN.2010111196.
98. A.Advani, Q.Huang, K.Thai, et al. Long-term administration of the histone deacetylase inhibitor vorinostat attenuates renal injury in experimental diabetes through an endothelial nitric oxide synthase dependent mechanism. Am J Pathol. 2011;178:2205–2214. doi:10.1016/j.ajpath.2011.01.044.
99. M.Pang, L.Ma, N.Liu, et al. Histone deacetylase 1/2 mediates proliferation of renal interstitial fibroblasts and expression of cell cycle proteins. J Cell Biochem. 2011;112:2138–2148. doi:10.1002/jcb.23135.
100. K.Kashani, A.Al-Khafaji, T.Ardiles, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care. 2013;17:R25. doi:10.1186/cc12734.